AstraZeneca (Pfizer Bid) Debate

Full Debate: Read Full Debate

Baroness McIntosh of Pickering

Main Page: Baroness McIntosh of Pickering (Conservative - Life peer)

AstraZeneca (Pfizer Bid)

Baroness McIntosh of Pickering Excerpts
Tuesday 6th May 2014

(10 years, 7 months ago)

Commons Chamber
Read Full debate Read Hansard Text

Urgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.

Each Urgent Question requires a Government Minister to give a response on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Vince Cable Portrait Vince Cable
- Hansard - - - Excerpts

I am obviously not going to give a running commentary on share prices today and tomorrow, but I repeat that throughout the industry, the big pharmaceutical companies have all been retrenching and creating redundancies because of the way technology has evolved. In fact, much of the dynamism in that industry—which I see frequently on my visits to universities—is through small spin-out companies. The nature of the industry is changing, and it is not just Pfizer that has been responsible for redundancies.

Baroness McIntosh of Pickering Portrait Miss Anne McIntosh (Thirsk and Malton) (Con)
- Hansard - -

Will the Business Secretary confirm that both European competition authorities and the British authority will test this process against the consumer interest? It cannot be in the consumer interest for research to be limited or for existing production lines in this country to be closed down.

Vince Cable Portrait Vince Cable
- Hansard - - - Excerpts

The European Commission must make up its own mind about whether it wishes to investigate this matter, but it will do so from the standpoint of competition policy, which implicitly takes into account consumer benefit.